MRNA 8-K 2026-01-12

Moderna, Inc. (MRNA) 8-K dated 2026-01-12 — accession 0001682852-26-000007. This URL is the filing, not the MRNA hub.

Moderna, Inc. (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..

Moderna, Inc. filed a 8-K on 2026-01-12. Accession 0001682852-26-000007.

Cached items: 2.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.

Not investment advice. The MRNA SEC hub lists recent forms. The stock page is the research view.